Activation of MAPK by potassium bisperoxo(1,10-phenanthroline)oxovanadate (V)

Potassium bisperoxo(1,10-phenantroline)oxovanadate (V) [bpV(phen)] is a potent protein tyrocine phosphatase inhibitor which mediates a variety of biological effects. The aim of these studies was to examine the role(s) of mitogen activated protein kinase (MAPK) pathways in PC12 cell proliferation and...

Full description

Saved in:
Bibliographic Details
Published in:Neurochemistry international 1999-04, Vol.34 (4), p.337-344
Main Authors: Cerovac, Zeljka, Ban, Jasna, Morinville, Anne, Yaccato, Karin, Shaver, Alan, Maysinger, Dusica
Format: Article
Language:English
Subjects:
51V-NMR
Animals
bisperoxo(1,10-phenanthroline)oxovanadate
Calcium-Calmodulin-Dependent Protein Kinases - metabolism
Cell Division - drug effects
Cell Survival - drug effects
Dose-Response Relationship, Drug
Drug Stability
Enzyme Activation
ERK
JNK
JNK Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinases
Organometallic Compounds - pharmacology
p38 Mitogen-Activated Protein Kinases
PC12 Cells
Peroxovanadium complexes
Phenanthrolines - pharmacology
Phosphorylation
Rats
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Potassium bisperoxo(1,10-phenantroline)oxovanadate (V) [bpV(phen)] is a potent protein tyrocine phosphatase inhibitor which mediates a variety of biological effects. The aim of these studies was to examine the role(s) of mitogen activated protein kinase (MAPK) pathways in PC12 cell proliferation and toxicity by bpV(phen). BpV(phen) exerts a bimodal effect in PC12 cells: proliferation at low and cell death at higher micromolar concentrations. Activation of MAPK by bpV(phen) depends on time and concentration. The phosphorylation pattern of extracellular regulated kinases (ERK 1/2), c-jun N-terminal activated kinases (JNK) and p38 in PC12 cells is strikingly different. Activation of JNK is sustained in PC12 cells. In contrast, ERK 1/2 activation is transient and treatment with PD98059 indicates that ERK activation by bpV(phen) is partly independent from the ras-MEK pathway. Stability studies of bpV(phen) in DMEM and PBS showed linear relationship with T1/2 about 6 h and 10 days in DMEM and PBS, respectively. Comparison between the time courses of MAPK activation and kinetics of bpV(phen) decomposition as assessed by 51V-NMR analysis show that the initial and maximal phosphorylation signals are produced in the presence of the complex bpV(phen) and not caused by the decomposition products of bpV(phen).
ISSN:0197-0186
1872-9754
DOI:10.1016/S0197-0186(99)00018-2